Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø and the Francis Crick Institute.
, More: Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø News